Macedo Arthur Cassa, de Faria André Oliveira Vilela, Bizzi Isabella, Moreira Fabrício A, Colasanti Alessandro, Ghezzi Pietro
Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
J Cannabis Res. 2022 Jul 11;4(1):37. doi: 10.1186/s42238-022-00145-w.
There is a growing literature on the potential medical uses of Cannabis sativa and cannabinoid compounds. Although these have only been approved by regulatory agencies for a few indications, there is a hype about their possible benefits in a variety of conditions and a large market in the wellness industry. As in many cases patients search for information on cannabis products online, we have analyzed the information on medical cannabis available on the Internet. Therefore, this study aims at assessing the quality of the information available online on medical cannabis.
We searched "medical cannabis" on June 2019 using google.com and downloaded the first 243 websites. After excluding dead links or websites with no information about cannabis, 176 websites were included. They were then classified for their typology (e.g., commercial, government, news outlets). As an indicator of trustworthiness, we used the Journal of American Medical Association (JAMA) score, which assesses the indication of date, author, ownership of the website, and the presence of references. We also considered if a website is certified by Health-On-the-Net (HON), an independent organization, by displaying a HONCode symbol. Subsequently, we performed a content analysis to assess both the medical cannabis indications mentioned by webpages and the completeness of the information provided (whether they mentioned potential side effects and legal/regulatory issues or not).
Analyzing 176 webpages returned by a search engine, we found that 52% of them were news websites. Pain, epilepsy, and multiple sclerosis were the most frequently mentioned therapeutic areas (cited in 92, 84 and 80 webpages, respectively), which did not always match those for which there is regulatory approval. Information was also incomplete, with only 22% of the webpages mentioning potential side effects. Health portal websites provided the most complete information, with all of them (n = 7) reporting side effects. On average, 80% of webpages had a neutral stance on the potential benefits of medical cannabis, with commercial websites having more frequently a positive stance (67%).
We conclude that the information that can be found online is not always aligned in terms of the therapeutic areas for which science-based evidence is often still weak.
关于大麻及其大麻素化合物潜在医学用途的文献越来越多。尽管这些仅在少数适应症上获得了监管机构的批准,但人们对其在各种病症中的潜在益处大肆炒作,且健康产业中有一个庞大的市场。正如在许多情况下患者会在网上搜索大麻产品的信息一样,我们分析了互联网上有关医用大麻的信息。因此,本研究旨在评估网上可得的医用大麻信息的质量。
2019年6月,我们使用谷歌在网上搜索“医用大麻”,并下载了前243个网站。在排除死链接或没有关于大麻信息的网站后,纳入了176个网站。然后根据其类型(如商业、政府、新闻媒体)进行分类。作为可信度的一个指标,我们使用了美国医学会杂志(JAMA)评分,该评分评估日期、作者、网站所有权的说明以及参考文献的存在情况。我们还考虑一个网站是否通过展示健康网(HON)代码符号而获得了独立组织健康网(HON)的认证。随后,我们进行了内容分析,以评估网页提到的医用大麻适应症以及所提供信息的完整性(是否提及潜在副作用和法律/监管问题)。
分析搜索引擎返回的176个网页,我们发现其中52%是新闻网站。疼痛、癫痫和多发性硬化是最常提及的治疗领域(分别在92、84和80个网页中被引用),这些并不总是与获得监管批准的领域相符。信息也不完整,只有22%的网页提及潜在副作用。健康门户网站提供的信息最完整,所有这些网站(n = 7)都报告了副作用。平均而言,80%的网页对医用大麻的潜在益处持中立态度,商业网站更常持积极态度(67%)。
我们得出结论,网上找到的信息在治疗领域方面并不总是一致的,而在这些领域基于科学的证据往往仍然不足。